Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY:XLV)

158.54 +1.72 (+1.10%)
Official Closing Price Updated: 4:00 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
42 43 Next >
News headline image
Tech In Orbit ↗
Tech has led the way higher with a sharp move this week. The sector is now extremely overbought, trading 3.23 standard deviations above its 50-DMA; the fifth most overbought reading on record. 
Via Talk Markets
News headline image
A Good Week For The Market But A Pause In The Biotech Rally ↗
Healthcare stocks have been lagging in 2023 with the XLV down 1.97% MTD and 3.34% YTD with CVS and UNH contributing to the weakness. 
Via Talk Markets
News headline image
Your Mid-May Market Update: Sector Strength And Weakness So Far In 2023 ↗
Today's session continued the ongoing theme of 
Via Talk Markets
News headline image
Good Odds And Odd Goods ↗
Investing is all about making money. It is the realm where you go find out where the odds are good, even if the goods are odd. 
Via Talk Markets
News headline image
5 Most-Loved ETFs Of Last Week ↗
Last week was marked by volatility. Overall, ETFs pulled in a modest $260 million in capital for the week, bringing total inflows of $111.7 billion year to date. 
Via Talk Markets
News headline image
Something Happened In Biotech Last Week ↗
Biotech stocks were more constructive last week with some sharp moves up. 
Via Talk Markets
News headline image
Seasonal Mid Point ↗
The next three months, which is the period straddling the back half of spring and the first half of summer, has been relatively strong in the last ten years. 
Via Talk Markets
News headline image
Regeneron Beats Q1 Views, But Stock Drops On Weak Eye Med Sales
Regeneron reported better-than-expected Q1 earnings and revenue, but its Eylea sales fell, losing ground to Roche's newly launched Vabysmo. 
Via MarketBeat
News headline image
6 Best Healthcare Stocks to Buy Right Now
Whether you invest in healthcare stocks for pharmaceuticals, medical devices or health insurance, the opportunities are limitless. Learn more with MarketBeat. 
Via MarketBeat
Topics Economy Intellectual Property
News headline image
Healthcare Sector Update: MedTech Trending Up ↗
Earnings from major device companies and large-cap biopharma over the next two weeks will help us ascertain risks for the market. 
Via Talk Markets
News headline image
Healthcare Innovation Drives Medical Device Makers To New Highs
Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base. 
Via MarketBeat
News headline image
Tuesday Talk: Eggs Still In The Basket ↗
Investors returned to the market Monday, after the Good Friday trading holiday, with most of their eggs still intact. The early Spring rally seems to be holding as the market prepares for Q1 banking... 
Via Talk Markets
News headline image
April Is Busting Out For Healthcare And Biotech ↗
Last week was a good week for healthcare stocks and most large cap biopharmaceutical stocks resumed an upward trend. 
Via Talk Markets
News headline image
Weekly Market Pulse: History Lessons ↗
Studying the past doesn’t somehow allow us to predict the future. But it does tell us that there is a range of potential outcomes and we should be reluctant to make big changes to our portfolios based... 
Via Talk Markets
News headline image
GILD - Chart Of The Week ↗
The daily chart looks pretty strong right now. The stock is trying to break through the resistance line that started around the beginning of December. 
Via Talk Markets
News headline image
Recession Playbook In Action: Cooling Labor Market Triggers Rally In Treasuries, Gold; Stocks Decline ↗
Recent economic data has prompted investors to hedge against the rising likelihood of a recession.  In February 2023, there were 9.9 million job openings, which was the lowest level since May 2021 and... 
Via Benzinga
News headline image
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags ↗
It was very difficult to make money in Q1 trading healthcare or biotech ETFs because of the sharp rally in other sectors. Nonetheless, there were two big winners. 
Via Talk Markets
News headline image
Financials And Tech Continue To Split: Your Sector Trade Ideas For The Week Ahead ↗
Current trade opportunities for Financials and Tech along with other sectors setting up trade logic. 
Via Talk Markets
News headline image
Energy & Financials Lead, But The Flight To Quality Has Begun ↗
It's easy to get suckered into thinking the crisis is over and buy the most oversold stocks. For financials, this comes with significant risk as the 
Via Talk Markets
News headline image
Can Healthcare Stocks Survive Macro Headwinds? ↗
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year. 
Via Talk Markets
News headline image
Sector Performance Experiences A Historical Divergence ↗
The first quarter of 2023 is coming to a close next week, and checking in on year-to-date performance, there has been a big divergence between the winners and losers. 
Via Talk Markets
News headline image
Small Cap Biotechs Slammed By SVB Collapse ↗
Nothing like a banking crisis to start off a weekend. But maybe by the end of this upcoming week of turmoil we'll worry less about inflation. 
Via Talk Markets
News headline image
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities ↗
 
Via Benzinga
News headline image
U.S. Weekly Fund-Flows Insight Report: Investors Embrace Both Fixed Income And Equity ETFs ↗
As investors appeared to ignore rising Treasury yields, stocks generally managed to remain on the plus-side for the fund-flows week. 
Via Talk Markets
News headline image
Covis Pharma To Withdraw Only FDA-Approved Treatment To Prevent Preterm Births ↗
 
Via Benzinga
News headline image
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason ↗
 
Via Benzinga
News headline image
A Market And Economy Exceeding Expectations ↗
Knowing the economy and investment market are not one and the same, and can function out of sync at times, possibly the current environment is such that they are actually in sync. 
Via Talk Markets
News headline image
S&P 500 2022 Q4 Earnings Review: Swing And A Miss ↗
In many ways, this quarter behaved in a way that met the expectations of most market commentators, earnings are too high, an erosion of pricing power since the pandemic, and that higher costs will bite... 
Via Talk Markets
News headline image
Identifying The Dimension Where Deterministic Chaos Is Alive In The Stock Market ↗
We have estimated approximate entropy for the S&P 500 and its SPDR ETF and we have noticed that all of them have non-linear dependence patterns for the dimension of 3 or 4 days. 
Via Talk Markets
News headline image
Tuesday Talk: My Sweet CPI ↗
The street is hoping for sweet January CPI data today and that anticipation pushed stocks higher on Monday. 
Via Talk Markets
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.